Phase II trial of gefitinib alone without radiation therapy for Japanese patients with brain metastases from EGFR-mutant lung adenocarcinomaToshihiko Iuchi, Toshihiko Iizasa, Yuzo Hasegawa et al.|Lung Cancer|2013Cited by 261
Frequency of brain metastases in non-small-cell lung cancer, and their association with epidermal growth factor receptor mutationsToshihiko Iuchi, Toshihiko Iizasa, Masato Shingyoji et al.|International Journal of Clinical Oncology|2014Cited by 167
Tyrosine kinase inhibitors alone as a first-line treatment for patients with non-small-cell lung cancer harboring mutant epidermal growth factor receptorToshihiko Iuchi, Hironori Ashinuma, Masato Shingyoji et al.|Annals of Oncology|2016Cited by 0
Tyrosine Kinase Inhibitors without Radiation Therapy for Brain Metastases from Egfr-Mutant Adenocarcinoma of LungToshihiko Iuchi, Toshihiko Iizasa, Yuzo Hasegawa et al.|Annals of Oncology|2012Cited by 0